Obesity and eye diseases

被引:254
作者
Cheung, Ning
Wong, Tien Y.
机构
[1] Univ Melbourne, Ctr Eye Res Australia, Retinal Vasc Imaging Ctr, Melbourne, Vic 3002, Australia
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore
关键词
age-related maculopathy; body mass index; cataract; eye disease glaucoma; obesity; pseudotumor celebri; retinal artery occlusion; retinal vein occlusion; retinopathy; BODY-MASS INDEX; OPEN-ANGLE GLAUCOMA; CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; C-REACTIVE PROTEIN; TYPE-1; DIABETIC-PATIENTS; HUMAN TRABECULAR MESHWORK; SYSTEMIC BLOOD-PRESSURE; BLUE-MOUNTAINS-EYE;
D O I
10.1016/j.survophthal.2006.12.003
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The prevalence of obesity has reached epidemic proportions in many countries. Although its impact on overall health is well documented, less is known about the ocular manifestations of obesity. Among different eye diseases, obesity has been linked with age-related cataract, glaucoma, age-related maculopathy, and diabetic retinopathy. Numerous population-based and prospective studies support an association between obesity and risk of age-related cataract. However, the nature and strength of these associations, particularly with the different cataract subtypes, remains to be determined. There is strong evidence that obesity is associated with elevated intraocular pressure, but there is no convincing data to support a more direct association between obesity and glaucomatous optic neuropathy. Studies to date have not found a consistent pattern of association between obesity and risk of age-related maculopathy or diabetic retinopathy. Thus, although obesity may be a risk factor for many ocular conditions, the present literature is inadequate to establish any convincing associations. Furthermore, whether weight loss reduces the risk of eye diseases remains unresolved. Because of the potential public health impact of obesity, there is a greater need to understand its ocular effects.
引用
收藏
页码:180 / 195
页数:16
相关论文
共 228 条
[41]  
Dowse GK, 1998, AM J EPIDEMIOL, V147, P448, DOI 10.1093/oxfordjournals.aje.a009470
[42]   Adiponectin: Novelties in metabolism and hormonal regulation [J].
Duntas, LH ;
Popovic, V ;
Panotopoulos, G .
NUTRITIONAL NEUROSCIENCE, 2004, 7 (04) :195-200
[43]   American Heart Association call to action: Obesity as a major risk factor for coronary heart disease [J].
Eckel, RH ;
Krauss, RM .
CIRCULATION, 1998, 97 (21) :2099-2100
[44]   Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration:: a preliminary study [J].
Evereklioglu, C ;
Doganay, S ;
Er, H ;
Çekmen, M ;
Özerol, E ;
Otlu, B .
EYE, 2003, 17 (03) :350-355
[45]   Adiponectin, obesity, and cardiovascular disease [J].
Fasshauer, M ;
Paschke, R ;
Stumvoll, M .
BIOCHIMIE, 2004, 86 (11) :779-784
[46]   Oxidative stress markers in aqueous humor of glaucoma patients [J].
Ferreira, SM ;
Lerner, SF ;
Brunzini, R ;
Evelson, PA ;
Llesuy, SF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (01) :62-69
[47]   A new treatment for ocular neovascularization [J].
Ferris, FL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2863-2865
[48]   Serum lipids and diabetic retinopathy [J].
Ferris, FL ;
Chew, EY ;
Hoogwerf, BJ .
DIABETES CARE, 1996, 19 (11) :1291-1293
[49]   The impact of ocular blood flow in glaucoma [J].
Flammer, J ;
Orgül, S ;
Costa, VP ;
Orzalesi, N ;
Krieglstein, GK ;
Serra, LM ;
Renard, JP ;
Stefánsson, E .
PROGRESS IN RETINAL AND EYE RESEARCH, 2002, 21 (04) :359-393
[50]   Overweight and obesity in the United States: prevalence and trends, 1960-1994 [J].
Flegal, KM ;
Carroll, MD ;
Kuczmarski, RJ ;
Johnson, CL .
INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (01) :39-47